Consistent with our observations in the triple-negative breast cancer cells, guides targeting Rosa26 exhibited minimal dropout over five passages, while guides targeting RPA3 or PCNA were depleted up to 90-fold (Figure 2—figure supplement 1). This evidence concerns the gene RPA3 and triple-negative breast carcinoma.